1. Home
  2. STKH vs BCTX Comparison

STKH vs BCTX Comparison

Compare STKH & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STKH
  • BCTX
  • Stock Information
  • Founded
  • STKH 2018
  • BCTX 2014
  • Country
  • STKH Israel
  • BCTX Canada
  • Employees
  • STKH N/A
  • BCTX N/A
  • Industry
  • STKH Packaged Foods
  • BCTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • STKH Consumer Staples
  • BCTX Health Care
  • Exchange
  • STKH Nasdaq
  • BCTX Nasdaq
  • Market Cap
  • STKH 21.6M
  • BCTX 21.8M
  • IPO Year
  • STKH 2021
  • BCTX N/A
  • Fundamental
  • Price
  • STKH $3.85
  • BCTX $13.88
  • Analyst Decision
  • STKH
  • BCTX Strong Buy
  • Analyst Count
  • STKH 0
  • BCTX 1
  • Target Price
  • STKH N/A
  • BCTX $40.00
  • AVG Volume (30 Days)
  • STKH 1.1M
  • BCTX 93.4K
  • Earning Date
  • STKH 11-21-2025
  • BCTX 10-16-2025
  • Dividend Yield
  • STKH N/A
  • BCTX N/A
  • EPS Growth
  • STKH N/A
  • BCTX N/A
  • EPS
  • STKH N/A
  • BCTX N/A
  • Revenue
  • STKH $10,000.00
  • BCTX N/A
  • Revenue This Year
  • STKH N/A
  • BCTX N/A
  • Revenue Next Year
  • STKH N/A
  • BCTX $380.95
  • P/E Ratio
  • STKH N/A
  • BCTX N/A
  • Revenue Growth
  • STKH N/A
  • BCTX N/A
  • 52 Week Low
  • STKH $3.56
  • BCTX $6.00
  • 52 Week High
  • STKH $123.20
  • BCTX $190.50
  • Technical
  • Relative Strength Index (RSI)
  • STKH 49.41
  • BCTX 70.49
  • Support Level
  • STKH $3.58
  • BCTX $11.75
  • Resistance Level
  • STKH $4.38
  • BCTX $14.68
  • Average True Range (ATR)
  • STKH 0.34
  • BCTX 1.01
  • MACD
  • STKH -0.09
  • BCTX -0.10
  • Stochastic Oscillator
  • STKH 35.46
  • BCTX 78.70

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.

Share on Social Networks: